KALV — Kalvista Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Kalvista Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 April 30th	2023 April 30th	2024 April 30th	2025 April 30th	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	8 M
Source:	10-K	10-K	10-K	10-K	10-KT
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	166	149	210	221	300
Net Total Accounts Receivable
Net Total Receivables	14.1	18.6	10.9	4.14	11.3
Total Inventory
Prepaid Expenses
Total Current Assets	194	172	226	242	320
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10	10.8	9.15	7.53	12.9
Other Long Term Assets
Total Assets	204	183	235	251	335
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.6	15	22.8	45.2	57.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.8	22.2	28.8	155	338
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	185	161	207	95.4	-2.71
Total Liabilities & Shareholders' Equity	204	183	235	251	335
Total Common Shares Outstanding